1. Home
  2. HNI vs NRIX Comparison

HNI vs NRIX Comparison

Compare HNI & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HNI

HNI Corporation

HOLD

Current Price

$41.43

Market Cap

2.5B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$23.97

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNI
NRIX
Founded
1944
2009
Country
United States
United States
Employees
N/A
357
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HNI
NRIX
Price
$41.43
$23.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
12
Target Price
$70.00
$30.50
AVG Volume (30 Days)
840.3K
3.2M
Earning Date
05-06-2026
04-08-2026
Dividend Yield
3.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,000,000.00
$76,987,000.00
Revenue This Year
$117.19
N/A
Revenue Next Year
$3.68
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
12.37
99.31
52 Week Low
$28.93
$8.20
52 Week High
$53.29
$24.88

Technical Indicators

Market Signals
Indicator
HNI
NRIX
Relative Strength Index (RSI) 77.28 77.77
Support Level $38.04 $14.63
Resistance Level $47.51 N/A
Average True Range (ATR) 1.66 1.35
MACD 0.82 0.66
Stochastic Oscillator 97.78 84.37

Price Performance

Historical Comparison
HNI
NRIX

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: